Indeed, in a heterogeneous cohort of 659 meningiomas, including primary and recurrent tumors, of all three CNS WHO grades, and with either total or subtotal surgical resection, CDKN2A/B HeDe was found in 15 cases in association with shorter progression-free survival [18]. The gene discussed is CDKN2A; the disease is meningioma.